Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce the sale of 9 CADScor Systems and 500 single-use patches to a prominent healthcare provider with 9 locations across 7 states in the US. This strategic purchase aims to establish the CADScor System as an integral part of their diagnostic workflow for assessing patients suspected of CAD.
With this initial acquisition, the healthcare provider has set a target to expand the usage of the system to at least 5 patches per day across each location.
“This sale underscores the growing adoption of the CADScor System in multi-site healthcare operations,” said Aamir Mahmood, CEO of Acarix. "We are thrilled to support our customers in delivering better diagnostic solutions, and we look forward to working closely with them to achieve their goal of increasing daily patch usage."
Forward-Looking Statements:
This press release contains forward-looking statements that involve risks and uncertainties, including statements regarding expected performance and usage targets.